GLAZER CAPITAL, LLC - 30 Jan 2025 SCHEDULE 13G Report for Revance Therapeutics, Inc. Common Stock, par value $0.001 per share (RVNC)

Filing Manager: GLAZER CAPITAL, LLC
Reporting Manager: Glazer Capital, LLC
Security: Revance Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: RVNC
Shares outstanding: 104,950,815 shares
Disclosed Ownership: 7,210,121 shares
Ownership: 6.9%
Form type: SCHEDULE 13G
Filing time: 06 Feb 2025, 18:19:06 UTC
Date of event: 30 Jan 2025
Next filing: 15 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Glazer Capital, LLC	6.9%	7,210,121	0	7,210,121	Paul J. Glazer	Paul J. Glazer, Managing Member
Paul J. Glazer	6.9%	7,210,121	0	7,210,121	Paul J. Glazer	Paul J. Glazer